Description: Tailored for newly minted ASAs/FSAs or those venturing into the realm of reserving, as well as seasoned actuaries in need of a recap, this session is a gateway to the mysteries of IBNR reserving, unraveling various methods and assumptions. Embark on a journey through the construction of claims triangles and the crafting of completion factors, delving into the enigmatic realms of seasonality, trend analysis, and outlier claims.

Description: Do your interests stop at your actuarial responsibilities of risk analysis, trend and rate submission? Reach beyond your role as the actuary. Become a leader-manager within the Market Segment Team and a trusted advisor to the P&L leader. Choosing your approach to working with the P&L leader determines your influence and impact on segment sustainability and success

Description: Patients with diabetes make up 25% of health care spending in the US, and a variety of solutions to address the high cost of diabetes exist today, including disease management programs, clinical interventions including bariatric surgery and GLP-1 drugs, and food as medicine programs.

Description: "Are you a health actuary affected by recent developments in business practices and accounting standards that have created situations in which you may be involved in estimating balances under accounting rules that differ from those typically used by insurers? In this session you will learn about situations where non-insurance accounting regimes may intersect actuarial practice, with an intended focus on two particular topics. One topic is general accepted accounting principles (GAAP) for insurance brokers under ASC 606 (Revenue Recognition) for commissions on Medicare Advantage and Medicare Supplement contracts, where the broker may get to recognize the expected value of all future commissions on a contract as revenue when the contract is placed. The other topic is GAAP under ASC 460 (Guarantees) in situations where a non-provider entity is bearing risk related to health care services, which can occur under the CMS Direct Contracting/ACO REACH model or under private sector care coordination contracts."

Description: Experience a comprehensive overview of the current purchasing landscape for health care services, with a specific focus on how healthtech start-ups can break into the employer-sponsored health care market. You will learn about the key players in the healthcare industry, as well as challenges that new entrants (+ B2B vendors more generally) face in selling their services to employers and health plans.

Description: The Patient Protection and Affordable Care Act (ACA) begins its second decade in a presidential election year. With a decade of experience, opinions on the law's policy efficacy are now rooted in data rather than forecasts. Hear two highly regarded policy experts discuss and debate various policy considerations related to the ACA and other current policy concerns in an actuary-moderated debate-style discussion.

Description: Four healthcare actuaries will share their personal stories of transitioning from pure actuarial roles to business leaders and how they’re putting their actuarial skills to work. All are experts within self-insured stop loss and medical reinsurance so they’ll discuss how their actuarial backgrounds supports the work they do today within this dynamic niche of healthcare.

Description: Anti-obesity medications have been met with reluctance from payers and employee benefits consultants who often lack analogs or empirical data to estimate the cost impact of new therapies coverage. Health plans considering coverage of anti-obesity medications will need to assess and manage the potential costs of covering these new therapies in context of their overall obesity management strategy, including coverage of nutrition counseling, weight management, and bariatric surgery.

Description: This session will bring together public health care leaders in COVID-10 vaccine delivery from both the U.S. and the UK to discuss and compare operational implications of the COVID-19 vaccine rollout in their countries, and how those programs ultimately affected hospitalization utilization and mortality rates for members of their communities.

Description: The purpose of this document is to inform the user of the 2021 Health Care Cost Model about the sources of data, other reports, and assumptions which were used to populate this report and drive some of the key considerations.